ACSL6 antibody
Principal name
ACSL6 antibody
Alternative names for ACSL6 antibody
ACS2, FACL6, KIAA0837, LACS5, Long-chain-fatty-acid--CoA ligase 6, Long-chain acyl-CoA synthetase 6
Ncbi ID
9606, NP_001009185.1, 5874, AAH26161.1, NM_001009185, NP_001009185, NP_056071, NP_001028770.1, NM_001033598, NM_001033599, NM_144823, NM_001033597, NM_130739, NM_015256
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of ACSL6 antibody
FACL6 is involved in activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. It plays an important role in fatty acid metabolism in brain and the acyl-CoAs produced may be utilized exclusively for the synthesis of the brain lipid. FACL6 is expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derieved from fetal liver, haemopoietic stem cells from cord blood, bone marrow, and brain. Expression is low at earlier stages of erythroid development but is very high in reticulocytes. This protein is involved in myelodysplastic syndrome (MDS) with basophilia, acute myelogenous leukemia (AML) with eosinophilia, and acute eosinophilic leukemia (AEL). It is characterized by a chromosomal translocation t(5;12)(q31;p13) that involves ETV6 and ACSL6.
General readings
Blanchard H, Taha AY, Cheon Y et al. iPLA2b Knockout Mouse, a Genetic Model for Progressive Human Motor Disorders, Develops Age-Related Neuropathology Neurochem. Res. 2014 Jun 12. PubMed PMID: 24919816
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA315237 | ACSL6 antibody |
||||||
| Rabbit polyclonal anti-ACSL6 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP01409PU-N | ACSL6 antibody |
||||||
 |
Rabbit | Aff - Purified | Hu, Ms, Rt | P, WB |
0.1 mg /
€370.00
|
||
| OriGene Technologies GmbH | |||||||
 +2 additional images |
|||||||
| AP12265PU-N | ACSL6 antibody |
||||||
 |
Rabbit | Ig | Purified | Hu, Ms | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP311883 | ACSL6 (transcript variant 2) |
||||
| Recombinant protein of human acyl-CoA synthetase long-chain family member 6 (ACSL6), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP316974 | ACSL6 (transcript variant 1) |
||||
| Recombinant protein of human acyl-CoA synthetase long-chain family member 6 (ACSL6), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY422907 | ACSL6 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR200807L2V | Lenti ORF particles, Acsl6 (GFP-tagged ORF) - Rat acyl-CoA synthetase long-chain family member 6 (Acsl6), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,460.00
|
|
| OriGene Technologies, Inc. | ||
| RR200807L1V | Lenti ORF particles, Acsl6 (Myc-DDK-tagged ORF) - Rat acyl-CoA synthetase long-chain family member 6 (Acsl6), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,310.00
|
|
| OriGene Technologies, Inc. | ||